On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The mystery behind China's aggressive push into space
- The best places to find love — and lust — according to science
- What would a U.S.-Russia war look like?
- Here's the schedule very successful people follow every day
- Sex can't explain the culture war
- Boyhood's refreshingly unsentimental take on motherhood
- Why GOP reformers are bound to fail
- The 5 best and worst states for a well-lived life
- How a drafting error could doom Obama's carbon regulations
- This simple hack for slicing cherry tomatoes will astound you
Subscribe to the Week